Literature DB >> 21482998

Successful treatment of relapsed and refractory extramedullary acute promyelocytic leukemia with tamibarotene.

Harris V Naina1, Daniel Levitt, Madhuri Vusirikala, Larry D Anderson, Pier Paolo Scaglioni, Angela Kirk, Robert H Collins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21482998     DOI： 10.1200/JCO.2011.34.8953

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

Review 1.  Contemporary treatment of APL.

Authors:  Elizabeth H Cull; Jessica K Altman
Journal:  Curr Hematol Malig Rep       Date:  2014-06       Impact factor: 3.952

2.  Extramedullary disease in acute promyelocytic leukemia: two-in-one disease.

Authors:  Francesco Albano; Giorgina Specchia
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-12-21       Impact factor: 2.576

3.  Long-term survival in an acute promyelocytic leukemia patient with recurrent granulocytic sarcomas: A case report.

Authors:  Xuehui Zhou; Chengwen Li
Journal:  Medicine (Baltimore)       Date:  2021-04-09       Impact factor: 1.817

4.  Multiple isolated extramedullary relapse of acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplant: a case report and review of literature.

Authors:  Shalin Kothari; Geoffrey Herzig; Stephen Slone; Roger Herzig
Journal:  Springerplus       Date:  2013-02-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.